GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptose Biosciences Inc (FRA:LTI0) » Definitions » Non Operating Income

Aptose Biosciences (FRA:LTI0) Non Operating Income : €0.65 Mil (TTM As of Mar. 2025)


View and export this data going back to 2014. Start your Free Trial

What is Aptose Biosciences Non Operating Income?

Non Operating Income is income or expense that comes from miscellaneous sources. Aptose Biosciences's Non Operating Income for the three months ended in Mar. 2025 was €0.00 Mil. Its Non Operating Income for the trailing twelve months (TTM) ended in Mar. 2025 was €0.65 Mil.

Aptose Biosciences Non Operating Income Historical Data

The historical data trend for Aptose Biosciences's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptose Biosciences Non Operating Income Chart

Aptose Biosciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Non Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 - -0.01 - 0.65

Aptose Biosciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Non Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 0.65 -

Aptose Biosciences Non Operating Income Calculation

Non Operating Income is income or expense that comes from miscellaneous sources.

Non Operating Income for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.65 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aptose Biosciences Non Operating Income Related Terms

Thank you for viewing the detailed overview of Aptose Biosciences's Non Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Aptose Biosciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptose Biosciences Inc (FRA:LTI0) » Definitions » Non Operating Income
Comparable Companies
TSXV:IBO TSXV:IOT TSXV:QPT XCNQ:LOBE TSXV:XRTX XCNQ:ASEP XCNQ:BLAB XCNQ:GLOW TSXV:RKV TSXV:MRVL VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
APTOF:USA 0UI8:UK APS:Canada
Address
66 Wellington Street West, Suite 5300, TD Bank Tower Box 48, Toronto, ON, CAN, M5K 1E6
Website
https://www.aptose.com
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.

Aptose Biosciences Headlines

No Headlines